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Reducing cervical cancer disparities in the U.S. requires intentional focus on structural barriers 
such as systems and policy which impact access to human papillomavirus (HPV) vaccination, 
cervical cancer screening and treatment. Such changes are difficult and often politicized. State 
comprehensive cancer control (CCC) plans are vehicles that, if designed well, can help build 
collective focus on structural changes.  
Study objectives were to identify the prioritization of cervical cancer in state CCC plans, the 
conceptualization of HPV within these plans, and the focus of plans on structural changes to 
reduce cervical cancer disparities.  Data were gathered by systematic content analysis of CCC 
plans from 50 states and the District of Columbia from February-June 2014 for evidence of 
cervical cancer prioritization, conceptualization of HPV, and focus on structural barriers to 
cervical cancer vaccination, screening or treatment.  
Findings indicate that prioritization of cervical cancer within state CCC plans may not be a 
strong indicator of state efforts to reduce screening and treatment disparities. While a majority 
of plans reflected scientific evidence that HPV causes cervical and other cancers, they did not 
focus on structural elements impacting access to evidence-based interventions.  
Opportunities exist to improve state CCC plans by increasing their focus on structural 
interventions that impact cervical cancer prevention, detection, and treatment; particularly for 
the 41% of plans ending in 2015 and the 31% ending between 2016-2020.  Future studies 
should focus on the use of policy tools in state CCC plans and their application to cervical 
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Introduction 
Cervical cancer remains among the top ten diagnosed cancers for African American and 
Hispanic women in the United States, despite dramatic declines in cervical cancer morbidity 
and mortality since the mid 20th century.(1) Incidence rates among these minority 
populations(2-8) and those who are uninsured(1,9-11) have remained relatively stable for the 
past several years,(12-13) suggesting that system characteristics are likely preventing 
population health improvement.  
 
Addressing systems problems and changing policies are examples of public health structural 
interventions because they alter the structural context for health.  Such interventions are not 
often favored because they involve addressing sociopolitical arrangements in the policy 
process. Examples of structural interventions to reduce U.S. rates of cervical cancer include, 
but are not limited to, Medicaid expansion and other health financing adjustments to maximize 
vaccination, screening and treatment access; strengthened human papillomavirus (HPV) 
vaccination requirements for adolescents; and the identification and establishment of 
alternative HPV vaccination venues such as pharmacies and schools.(14)  State efforts to 
enact such structural interventions often meet with high levels of politicization as well as 
resistance to policy implementation. Despite such challenges, policy-based structural 
interventions are often required, because public health is centrally about addressing the 
conditions that affect the health of populations.(15)  
 
There have been efforts to assist community development of structural interventions. In 2010, 
the Centers for Disease Control and Prevention (CDC) provided 2-year funding to 50 
communities across the U.S. to develop policy, systems and environmental interventions 
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(“PSE”) to reduce obesity, tobacco use and second hand smoke exposure.(16) Thirty-two 
states received funding for area (urban/rural) and topic specific (obesity/tobacco) community 
action planning. That same year, CDC provided 5-year funding to 13 states to demonstrate the 
capacity of comprehensive cancer control programs to implement policy and environmental 
cancer control interventions. The intent of the funding was to develop capacity to prioritize and 
track state and local cancer control policy changes.(17) 
 
An important vehicle for communicating structural change is the state-level comprehensive 
cancer control (CCC) plan. Well-designed CCC plans can facilitate structural efforts because 
they have the potential to broaden the base of support for change through strategic direction 
for advocacy, funding, and system change. State CCC plans are an example of what has been 
called ‘small p’ policy expressions,(18) because while not developed by elected officials, these 
plans are established and supported by state agencies and partners with the potential for 
broad population-level impact.  
 
CCC plans are the result of a long-standing funding partnership between the Centers for 
Disease Control and Prevention (CDC) and states, territories and tribal organizations to 
coordinate and align the many cancer efforts toward common goals, objectives and strategies. 
Initiated in 1998 among five states, CCC planning is now conducted in all 50 states and the 
District of Columbia, seven tribal nations and in seven U.S. territories and Pacific Island 
jurisdictions.(19-21) Evaluations of these plans have focused on their accomplishments,(22-
23) strength of the plan elements themselves (plan organization, use of evidence, clearly 
stated objectives, and mapping of funding to objectives),(17,24) and specific focus area such 
as genomics content, colorectal screening and HPV vaccination.(18,25-27)  
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Dramatically reducing or even eliminating U.S. cervical cancer disparities is within our grasp 
with extant public health tools of vaccination, screening and early treatment. Therefore, we 
present here results from a systematic review of state CCC plans in all 50 states and the 
District of Columbia to see whether these cervical cancer prevention tools are emphasized, 
and whether structural interventions are among the stated strategies to address cervical 
cancer.  Study objectives were to identify the prioritization of cervical cancer in state 
comprehensive cancer plans, understand the conceptualization of HPV in these plans, and to 
identify evidence of structural interventions focused on likely systems and policy barriers in the 
fight against cervical cancer. 
 
Materials and Methods 
A systematic content analysis of CCC plans for the 50 states and District of Columbia was 
conducted between February and June 2014. Plans were accessed from the National 
Comprehensive Cancer Control Program of the CDC.(28) Jurisdictions with out-of-date plans 
were contacted by email to submit a more current plan by May 30, 2014.  
 
A content analysis instrument was developed to gather text evidence of plan content focused 
on cervical cancer, cancer plan characteristics, and state characteristics. Indicators of plan and 
state characteristics were gathered to contextualize the analysis and allow for comparison 
between states. We abstracted data on cervical cancer plan content using the following 
measures: cervical cancer prioritization (whether cervical cancer was listed among the top 5 or 
top 10 cancer priorities); conceptualization of HPV (whether plan language articulated a 
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relationship between HPV and cervical cancer and/or other cancers); and evidence of 
structural interventions to address cervical cancer. Cancer plan characteristics included the 
age of the plan (current, out of date), time period (years covered), cycle (newly initiated, mid, 
end), and endorsement (governor, legislative, state agency). Planning cycle was defined as 
follows: “newly initiated” referred to those plans beginning no earlier than 2013, “mid-cycle” 
referred to plans ending in the years between 2016-2020, and “end” referred to plans ending 
their cycle in 2015. State characteristics of interest included state population size, region 
(census region and division),(29) and cervical cancer incidence and mortality.(30) State health 
access indicators included the proportion of women ages 19-64 years who were uninsured in 
2013;(31)proportion of women without a health care provider or personal doctor in 2010-
2012;(32) and HPV vaccine completion rates of >2 doses for girls and for boys in 2013.(33) 
Health related access policies of interest included whether state had expanded Medicaid (or 
has plans to expand);(34) whether the state had expanded access for family planning services 
under a state Medicaid plan waiver (which expands cervical cancer screening and follow-
up);(35) and whether the state had religious or religious plus philosophical exemptions from 
school immunization requirements in 2012.(36) State funding indicators of interest included 
state, CDC and HRSA per capita public health investments;(37) whether the state had a grant 
from CDC for policy and environmental programs interventions;(38) whether the state had 
community that was funded by CDC under the Communities Putting Prevention to Work to 
focus on PSE strategies for tobacco, obesity or both;(16) per capita CDC cancer prevention 
and control funding;(39) per capita funding to increase HPV vaccination coverage rates among 
adolescents;(40) and the state vaccine funding regime in 2011.(41) Vaccine funding regime 
refers to state financing and supply policy for childhood vaccination (up to 18 years of age) for 
private providers. State funding regimes are commonly classified into 5 categories: “universal 
purchase,” meaning that the state supplies all routinely recommended childhood vaccines to all 
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participating private providers regardless of insurance status; “universal purchase select,” 
meaning that the state supplies many but not all of the recommended vaccines regardless of 
insurance status with the remainder provided only for Vaccine For Children (VFC) eligible 
children; “VFC and underinsured,” meaning that the state supplies all recommended vaccines 
for VFC-eligible and underinsured children; “VFC and underinsured-select,” meaning that the 
state supplies many, but not all recommended vaccines for VFC and underinsured children 
with the remaining available only to VFC-eligible children; and “VFC only,” meaning that the 
state supplies recommended vaccines only for VFC-eligible children. See Table 1. 
 
Two independent investigators developed a codebook based on research objectives. A coding 
conference was held after the first 12 CCC plans were reviewed to assess reliability, confirm 
clarity and to identify and manage coding discrepancies. All CCC plans were reviewed with a 
revised and improved data-gathering instrument.  
 
Most measures were straightforward, with the exception of HPV conceptualization and 
evidence of structural intervention strategies for cervical cancer. Qualitative statements in the 
CCC plan about HPV were coded as having no reference to cervical cancer, reference as a 
cause of cervical cancer; and reference as a cause of cervical and other cancers. Dummy 
variables were created to test bivariate associations between state, plan and cervical cancer 
plan content characteristics. CCC plan cervical cancer-related goals, objectives and strategies 
were coded as having structural focus using an a priori framework based on the work of 
Blankenship and colleagues,(42) if focused upon the structural causes of disease or risk for 
cervical cancer. These include: community mobilization focused on altering the balance of 
power to advance other changes, institutional delivery system improvements, funding policies, 
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economic interventions and policy change. Strategies had to be well-articulated to be coded as 
structural. So, for example, a plan that stated a need to expand funding for free screening but 
did not fully articulate strategies to do so were not coded as having a structural intervention.  
 
Associations between CCC plan content related to cervical cancer, plan characteristics, and 
state characteristics (including health access and funding) were tested using ANOVA and X2 
testing with Fisher’s Exact Test as appropriate. Significance of observations were noted when 
significant at p <.05 level. 
 
Results 
CCC plans from 50 states and the District of Columbia were reviewed for the study. The 
majority of CCC plans were 4-year (41.2%) and 5-year (43.1%) in scope, with a range from 1-
10 years. Most plans (80.4%) were current. In terms of planning cycle, 7.8% were “newly 
initiated;” or beginning no earlier than 2013, 41.2% of plans were nearing the end of their cycle 
in 2015, and 31.4% of plans were classified as “mid-cycle,” or ending in the years between 
2016-2020.  Pacific division states tended to have out-of-date plans (AK, OR, WA: p<.05); 
states from the West North Central division tended to be in mid planning cycle (IA, KS, MN, 
NE, ND: p<.05) and East North Central division states tended to have plans ending in 2015 (IL, 
IN, MI, OH, WI: p<.01). See Table 2. 
 
Prioritization of Cervical Cancer 
Discerning the prioritization of cervical cancer in the CCC plans was a bit difficult, as 45.1% of 
plans contained priorities that were not clearly ordered. However, 21.6% of plans identified 
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cervical cancer among the top 5 priorities, 13.7% listed cervical cancer as 6th-10th in priority, 
and 19.6% of plans did not list cervical cancer among the CCC plan priorities. See Figure 1. 
 
Plans identifying cervical cancer among the top 5 priorities were most likely initiated since 
2013 (p=.03), had been from states with higher rates of cervical cancer among Hispanic 
women in 2009 [F(1,15)=7.2, p=.02], and had been developed by states having a philosophical 
exemption for vaccination in 2012 (p=.03). See Table 3. 
 
All plans but one addressed cervical cancer; though not all plans mentioned HPV, the proven 
cause of virtually all cervical cancers. Six plans (11.8%) did not mention HPV at all (PA, NV, 
MT, IL, ID, HI). This may be a function of timing with dissemination and adoption of scientific 
evidence, as all but the Pennsylvania plan were ending by 2016. This notwithstanding, 
statistical significance between plan phase and absence of HPV was not observed.   
 
Of the 45 CCC plans discussing HPV, the majority (57.8%) conceptualized HPV only in terms 
of cervical cancer. Almost half (42.4%) of plans conceptualized HPV as being linked with many 
cancers. CCC plans conceptualizing HPV in terms of its relationship to many cancers tended 
to have more recent implementation dates of 2013 and later. Further, plans articulating a 
relationship between HPV and cervical cancer tended to list cervical cancer among the top 5 
priorities. Notably, plans that articulated HPV’s relationship to many cancers did not prioritize 
cervical cancer at all. See Table 4. 
 
Approach to Cervical Cancer 
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The vast majority (80.4%) of state CCC plans were educational in orientation, with the focus at 
the individual behavior change level. Examples include increasing screening or vaccination 
uptake by individuals or communities through public education about screening availability and 
about HPV vaccination. Clinician behavior change was the primary focus for 41.2% of the state 
plans. Here, the targeted behavior was to increase screening or vaccination provision through 
guidelines education. Only 6 (11.7%) plans identified policies or policy change for collective 
attention (AK, CT, DE, MI, NV, NJ). Policies described included third party coverage for Pap 
and HPV testing, requirements for targeted parental education about HPV vaccine for 6th grade 
girls (specifically), increased funding (general and VFC coverage) to purchase HPV vaccine for 
girls and boys, and Medicaid expansion. In each of these cases, however, listed strategies 
included only mild references to advocacy or coalition building without any additional strategic 
direction about how these changes were going to be attempted or supported. Notably, only 2 
of the 6 states were recipients of the 2010 policy and environmental funding initiatives. 
Michigan received the 5-year policy tracking capacity funding, and Nevada received the 2-year 
community-level structural intervention planning funding. In these two cases, it is unclear 
whether state plans reflected policy learning from the funding initiatives, because while 
Michigan’s plan was from 2009-2015, it was revised in 2012. Nevada’s plan was from 2011-
2015, with no evidence of revision during the time period. 
 
Discussion 
Several observations emerge from this systematic review of state CCC plans. First, it appears 
that scientific discoveries about the connection between HPV and cancers are being heard and 
encoded in state plans. This reference primarily occurs in discussion sections or epidemiologic 
profiles within the plans. The translation of this evidence into implementable plans to increase 
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HPV vaccination and screening with HPV diagnostic tests, however, is not fully clear. Some 
state CCC plans recognized the connection between HPV and cancers but did not articulate 
strategies to increase vaccination or screening.  
 
Second, the planning around cervical cancer remains focused largely at the individual level: 
change the individual behavior of patients and providers. While some plans noted the 
structural barriers of insurance, unsupportive vaccine policy environments or underfunded 
systems of screening and follow-up, there was a paucity of strategies addressing these issues.  
The lack of structurally focused state CCC plans and articulated evidence-based structural 
interventions to address cervical cancer is of great concern and warrants future studies of the 
potential for utilization of policy tools in plans to help facilitate future adoption of policy and 
structurally related planning.  
 
Third, it was surprising to note the lack of association between various state policy 
characteristics and plan content. We assumed there to be associations with structural 
indicators such as public health funding, existing vaccine policy and screening expansion 
policies (such as Medicaid expansion or waiver); though, it was not necessarily clear what 
direction those associations might have. Future structural level studies should continue to 
refine the selection of these indicators, as there may in fact be a link or association that we do 
not yet see. Notably, we did not observe associations between receipt of policy development 
funding and structural interventions or advocacy planning.  This may be an issue of timing, as 
both funding mechanisms were initiated in 2010. Perhaps time and policy learning will result in 
the observation of planned structural or systems level changes and advocacy for them. 
 
Cancer Research. 
on June 18, 2021. © 2015 American Association forcancerpreventionresearch.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on May 5, 2015; DOI: 10.1158/1940-6207.CAPR-15-0004 
 13
Finally, it is possible that prioritization of cervical cancer does not represent a reliable marker 
of whether cervical cancer is actually prioritized, because almost half of plans (45.1%) did not 
prioritize specific cancers. That a state plan prioritizes cervical cancer does not mean 
strategies will be evidence-based or structural in nature. Further, plans that did not explicitly 
prioritize cervical cancer often contained strategies addressing it.    
 
It is important to recognize that while state CCC plans shared several characteristics, state 
plans varied considerably. Even as the federal government finances the state CCC planning 
effort, there is room for state flexibility to develop plans that are reflective of the greatest 
cancer burdens in these jurisdictions, and can be advanced by statewide partners. Advising 
states about the structural change opportunities presented by CCC planning would be a wise 
endeavor as evidence begins to emerge. 
 
Several opportunities exist to encourage the inclusion of strategies focused on structural or 
policy issues in CCC plans. Almost half of the plans (41.2%) are nearing the end of their 
planning cycle in 2015 and can take time to focus on how they are addressing cervical cancer 
and HPV in their plans. Understanding perceptions of planners about actual and perceived 
barriers to HPV specific planning as well as barriers to structurally based planning generally 
would allow for greater interpretation of these observations.  
 
As we move away from disease specificity in our policy and planning to focus more on 
structural aspects which impact populations across cancers, we may find that it is easier to 
focus on structural interventions and related preparations for them such as coalition building 
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across cancer specific coalitions. This would help states and their cancer control partners tap 
into a broader base of supporters for the difficult and necessary changes required to 
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Table 1: State Comprehensive Cancer Control Plan Study Variables 
 
Selected Comprehensive Cancer Control Plan Content 
Plan priorities 
Ranking of cervical Cancer (among the top 5 priorities, among 6-10th priorities) 
 
Conceptualization of Human papillomavirus 
• Mention of HPV in plan 
• HPV’s relationship to cervical and other cancers  
 
Evidence of structural interventions 
• Strategies focused on financing, systems or policy  
• Primary emphasis of strategies (if not structural) 
Comprehensive Cancer Control Plan Characteristics 
Age of plan 
• Current/out of date 
• Plan cycle (beginning, mid, end) 
 
Plan endorsement - Governor, legislature, state health agency 
State Characteristics 
• State population 2013 
• US census region, division 
• % women ages 19-64 who were uninsured in 2013 
• % women without a health care provider or personal doctor, 2010-2012 
• Cervical Cancer morbidity and mortality rates by race/ethnicity, 2009 
• % HPV vaccination coverage of >2 doses for boys 
• % HPV vaccination coverage of >2 doses for girls 
 
Access policies: 
• Expanding Medicaid? (Yes/No) 
• Medicaid waiver to expand family planning services? (Yes/No) 
• Philosophical exemption for vaccination (Yes/No) 
• Religious exemption for vaccination (Yes/No) 
 
Funding 
• State per capita public health investment (2010-2011, 2011-2012, 2012-2013) 
• CDC and HRSA per capita funding to the state (2013) 
• Policy and environmental program interventions funding, 2010 (5-year) (Yes/No) 
• Communities putting prevention to work with PSE for tobacco and/or obesity, 2010 (2-year)  
(Yes/No) 
• Per capita CDC Cancer prevention and control funding (2013) 
• Per capita funding to increase HPV vaccination among adolescents (2013) 
• State vaccine funding regime (Universal, Universal-select, VFC and underinsured, VFC and 
underinsured-select, VFC only) 
US= United States; CDC=Centers for Disease Control and Prevention; HRSA=Health Resources and Services Administration; 
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Table 2: Overview of Comprehensive Cancer Plan Characteristics in 50 





Out of date 10(19.6)
Initiated since 2013 4(7.8)
Middle of cycle 16(31.4)











8 or 10-year 2(3.9)
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Table 3: Prioritization of Cervical Cancer in Comprehensive Cancer Control 
Plans in 50 States and the District of Columbia 
 
 Morbidity and 
Mortality 
 
Higher Rates of 
Cervical Cancer 




coverage of > 
2 doses, 2013 




Unclear F=4.8*    
Not 
prioritized 
 For boys 
F=5.5* 
Plans of 8 or 
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Table 4: HPV Conceptualization and State Characteristics Among 














































F=4.8* South Atlantic 
X2=7.7** 
X2=6.0* X2=4.0* 
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Figure 1: Prioritization of Cervical Cancer in Comprehensive Cancer Plans by Census Regions 
and Divisions (N=51) 
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